Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06099418
Title Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors Nykode Therapeutics ASA
Indications
Therapies
Age Groups: adult | senior
Covered Countries


No variant requirements are available.